New perspectives in clinical oncology from angiogenesis research (Q41372777)

30 September 2017

1 reference

title

New perspectives in clinical oncology from angiogenesis research (English)

1 reference

30 September 2017

1 reference

Folkman J

1

1 reference

30 September 2017

1 December 1996

1 reference

European Journal of Cancer

30 September 2017

1 reference

30 September 2017

32A

1 reference

30 September 2017

14

1 reference

30 September 2017

2534-2539

1 reference

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Dormancy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

The Walter Hubert Lecture, 1982. Interaction of cancer and host

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Induction of apoptosis in fibroblasts by c-myc protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Oncogenes and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Local Recurrences Following Mastectomy: Support for the Concept of Tumor Dormancy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Analysis of experimental antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Fighting cancer by attacking its blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Vascular attack as a therapeutic strategy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Barriers to drug delivery in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

Tumor angiogenesis and tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900423-6

7 January 2021

10.1016/S0959-8049(96)00423-6

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9059344